High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis

<table>Changes in creatine kinase (CK) activity over time after SCIg initiation. Improvement in CK values was observed from the first month after the initiation of SCIg, up to 7 months.</table>

Case Reports in Rheumatology

fig1

Figure 1

Figure 1: High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis 